BRAIN BIOTECH AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.78 EUR | -1.77% |
|
-0.36% | -22.99% |
| 05-28 | BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
| 04-16 | Brain Biotech Plans Merger by Absorption of AnalytiCon Discovery | MT |
Evolution of the average Target Price on BRAIN Biotech AG
Price target over the last 5 years
History of analyst recommendation changes
4bf56d016.SI2QMRzoSN4NBQ2kDHJsrxDucGl-9_NsrJnts0s9_Fs.AfimR2jFHLxeQUDoaxcB52SiKiYqlN489dOd3QFFrHYP-_hZU7AHlzhCSA~c2f382b65d459bd3ea9fec9e6bce0a7e
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.8
EUR
Average target price
10.98
EUR
Spread / Average Target
+291.96%
High Price Target
15
EUR
Spread / Highest target
+435.71%
Low Price Target
4.1
EUR
Spread / Lowest Target
+46.43%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- BNN Stock
- BNN Stock
- Consensus BRAIN Biotech AG
